Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Equity Average (2016 - 2025)

Historic Equity Average for Orthofix Medical (OFIX) over the last 15 years, with Q3 2025 value amounting to $450.4 million.

  • Orthofix Medical's Equity Average fell 1596.14% to $450.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $450.4 million, marking a year-over-year decrease of 1596.14%. This contributed to the annual value of $550.9 million for FY2024, which is 1777.1% up from last year.
  • Latest data reveals that Orthofix Medical reported Equity Average of $450.4 million as of Q3 2025, which was down 1596.14% from $458.3 million recorded in Q2 2025.
  • Orthofix Medical's 5-year Equity Average high stood at $652.1 million for Q2 2023, and its period low was $335.2 million during Q4 2022.
  • Moreover, its 5-year median value for Equity Average was $458.3 million (2025), whereas its average is $460.4 million.
  • As far as peak fluctuations go, Orthofix Medical's Equity Average skyrocketed by 9248.76% in 2023, and later plummeted by 1788.72% in 2025.
  • Quarter analysis of 5 years shows Orthofix Medical's Equity Average stood at $350.9 million in 2021, then fell by 4.47% to $335.2 million in 2022, then skyrocketed by 81.12% to $607.1 million in 2023, then decreased by 15.25% to $514.5 million in 2024, then decreased by 12.46% to $450.4 million in 2025.
  • Its Equity Average was $450.4 million in Q3 2025, compared to $458.3 million in Q2 2025 and $480.7 million in Q1 2025.